Evolent Health

Evolent Health P/B

The P/B (Price-to-Book Ratio) of Evolent Health (EVH) as of Nov 1, 2026 is 0.75. In the previous year, P/B (Price-to-Book Ratio) was 0.31 — a change of 141.15% (higher).

P/B

0.75

YoY

141.15%

Last updated:

P/B (Price-to-Book Ratio) of Evolent Health is 2025 0.75 . P/B (Price-to-Book Ratio) of Evolent Health was 2024 0.31 . It decreases by 141.15% higher compared to the previous year.

The Evolent Health P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
0.26 USD
Jan 1, 2019
0.34 USD
Jan 1, 2020
0.50 USD
Jan 1, 2021
0.45 USD
Jan 1, 2022
0.36 USD
Jan 1, 2023
0.29 USD
Jan 1, 2024
0.31 USD
Jan 1, 2025
0.75 USD
The Evolent Health P/B history
YEARP/BYoY
0.75+141.15%
0.31+6.64%
0.29-19.51%
0.36-19.29%
0.45-10.67%
0.50+48.86%
0.34+28.95%
0.26-12.03%
0.30-12.83%
0.34-28.81%
0.48-100.32%
-150.42—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Evolent Health Stock analysis

What does Evolent Health do? Evolent Health Inc was founded in 2011 and is a healthcare services company based in Arlington, VA USA. The company was founded by a group of CEOs and executives to revolutionize the healthcare system and reduce healthcare costs in the US. Evolent, a wordplay on "evolution" and "diligent," is committed to improving healthcare services through innovative ideas and technologies. Over the years, Evolent Health's business model has evolved and expanded to meet the needs of a wide range of healthcare organizations and their patients. The company works with healthcare organizations such as hospitals, medical centers, health plans, and physicians to provide effective and affordable healthcare solutions. Evolent Health offers various services tailored to the needs of different healthcare organizations. One of their core competencies is the development and implementation of population health management programs. These programs aim to improve patient health while reducing costs. The company also offers technology platforms that healthcare organizations can use to manage data, improve treatment outcomes, and facilitate communication between doctors and patients. Another important aspect of Evolent Health is the care of Medicare and Medicaid patients. The company works with health plans to provide better healthcare services to these underserved populations. Evolent Health also offers specialized services, such as the treatment of patients with chronic conditions like diabetes or cardiovascular diseases. In recent years, Evolent Health has also expanded its portfolio through acquisitions and partnerships. In 2018, two acquisitions were completed, namely Valence Health and New Century Health. These acquisitions have strengthened Evolent Health's position in the field of population health management programs and specialized services for cancer patients. Another innovative product of Evolent Health is the Virtual Health Center. This program offers virtual consultations and treatments for patients who cannot make in-person visits to doctors due to distance or busy lifestyles. The program utilizes state-of-the-art telemedicine technology to provide patients with high-quality medical care while allowing them to stay comfortably at home. Evolent Health has an impressive track record in improving patient outcomes and reducing healthcare costs. In 2020, the company received the highest rating in the "Population Health Management" category of the Healthcare Informatics 100 Rankings. The company serves nearly 3 million patients in the US and operates in over 30 states. Overall, the company has the potential to change the healthcare system in the US and beyond through its vision, innovation, and commitment to high-quality healthcare services. Evolent's focus on improving healthcare delivery and reducing costs has the potential to be a role model for the entire industry. Evolent Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolent Health stock

P/B (Price-to-Book Ratio) of Evolent Health is 0.75 in 2025.

P/B (Price-to-Book Ratio) of Evolent Health changed from 0.31 to 0.75, representing a 141.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Evolent Health since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Evolent Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Evolent Health

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Evolent Health